Fulcrum Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.
/ 
Frequently asked questions
To buy Fulcrum Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Fulcrum Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Fulcrum Therapeutics Inc. is FULC:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Fulcrum Therapeutics Inc. has its primary listing on NASDAQ. You can trade Fulcrum Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Fulcrum Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Fulcrum Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Fulcrum Therapeutics Inc. or others.